Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Surg. 2013 Mar;205(3):289-92; discussion 292. doi: 10.1016/j.amjsurg.2012.10.020. Epub 2013 Jan 22.

Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens.

Author information

  • 1Department of Colorectal Surgery, c/o Colorectal Physicians & Surgeons of Pennsylvania, Saint Vincent, 145 West 23rd Street, Suite 201, Erie, PA 16502, USA.

Abstract

BACKGROUND:

We evaluated the effect of neoadjuvant therapy (NAT) on lymph node harvest in rectal cancer patients undergoing anatomic resection with curative intent.

METHODS:

A prospectively maintained database was retrospectively queried for rectal cancer cases from 1990 to 2010. Demographic data, NAT, and lymph node yield were analyzed. Nonanatomic resections were excluded.

RESULTS:

Five hundred two cases were identified; the mean age was 68 years (range 34-89), and 56% were men. One hundred fifty-one (30%) patients received NAT. Overall, the lymph node yield was diminished in proctectomy specimens after NAT (mean = 9, median = 7) compared with specimens without therapy (mean = 13, median = 10, P = .001). Age was not a significant factor in the lymph node yield (P = .213 and .329). Among patients treated with NAT, younger patients had a significantly lower lymph node yield (P < .0001).

CONCLUSIONS:

A decreased lymph node yield in proctectomy specimens from patients treated with NAT is consistent with prior studies. Younger patients had a greater reduction in lymph node harvest after NAT compared with senior patients.

Copyright © 2013 Elsevier Inc. All rights reserved.

PMID:
23351510
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk